May 13, 2004 — About one third of sildenafil nonresponders respond to intraurethral alprostadil treatment for erectile dysfunction (ED), according to the results of a small study published in the May ...

Men with coronary artery disease who used phosphodiesterase-5 (PDE-5) inhibitors for erectile dysfunction had fewer adverse cardiovascular events than those taking the prostaglandin drug alprostadil ...

Please provide your email address to receive an email when new articles are posted on . In a comparison of two erectile dysfunction medications in men with stable CAD, phosphodiesterase type 5, or ...

Use of a phosphodiesterase type-5 (PDE5) inhibitor was associated with a lower risk for death and cardiovascular events than alprostadil for the treatment of erectile dysfunction in men with stable ...

A 63-y-old man attended the erectile dysfunction clinic. He was initially treated with intracavernosal injection of 20 μg alprostadil (Viridal®). Due to the poor response he used intraurethral ...

A voluntary recall of the erectile dysfunction treatment, Edex (alprostadil for injection) was announced due to a defect in the crimp caps used in the manufacturing of the product lot. Endo announced ...

This article was reviewed by Kelly Brown MD, MBA. For men who don’t respond to oral ED medications like Viagra, Trimix injections can be a game-changer. It’s an injectable ED medication you insert ...